Opportunities and challenges in the therapeutic activation of human energy expenditure and thermogenesis to manage obesity

Abstract

<jats:p>The current obesity pandemic results from a physiological imbalance in which energy intake chronically exceeds energy expenditure (EE), and prevention and treatment strategies remain generally ineffective. Approaches designed to increase EE have been informed by decades of experiments in rodent models designed to stimulate adaptive thermogenesis, a long-term increase in metabolism, primarily induced by chronic cold exposure. At the cellular level, thermogenesis is achieved through increased rates of futile cycling, which are observed in several systems, most notably the regulated uncoupling of oxidative phosphorylation from ATP generation by uncoupling protein 1, a tissue-specific protein present in mitochondria of brown adipose tissue (BAT). Physiological activation of BAT and other organ thermogenesis occurs through β-adrenergic receptors (AR), and considerable effort over the past 5 decades has been directed toward developing AR agonists capable of safely achieving a net negative energy balance while avoiding unwanted cardiovascular side effects. Recent discoveries of other BAT futile cycles based on creatine and succinate have provided additional targets. Complicating the current and developing pharmacological-, cold-, and exercise-based methods to increase EE is the emerging evidence for strong physiological drives toward restoring lost weight over the long term. Future studies will need to address technical challenges such as how to accurately measure individual tissue thermogenesis in humans; how to safely activate BAT and other organ thermogenesis; and how to sustain a negative energy balance over many years of treatment.</jats:p>

Estrogen-Related Receptor Alpha: An Under-Appreciated Potential Target for the Treatment of Metabolic Diseases

“…It is a hallmark of type 2 diabetes and is a major contributor to the development of NAFLD and vice versa [102]. While obesity is associated with chronic inflammation that leads to insulin resistance and NAFLD [90], mitochondrial dysfunction is involved in all three metabolic disorders [102][103][104][105]. Most notably, mitochondrial defects in FAO lead to the accumulation of intracellular fatty acid metabolites such as dihydroxyglycerol and ceramides that adversely affect insulin signaling in various tissues [106][107][108].…”

Adipocyte-specific deletion of the oxygen-sensor PHD2 sustains elevated energy expenditure at thermoneutrality

“…Several elegant studies have identified approaches to activate thermogenic brown adipose tissue (BAT) and enhance metabolism (1)(2)(3). However, the majority of these experiments were conducted on rodents at ambient temperature (19-21 o C), a condition where BAT is already active (4)(5)(6).…”

Innervation of supraclavicular adipose tissue: A human cadaveric study

“…While pharmacological intervention is also an option, these drugs (i.e. glucagon-like peptide-1 receptor agonists, or adrenergic receptor agonists) typically have gastrointestinal or cardiovascular side effects [8,9].…”